Watching proceedings today adds ‘credibility’ to the theory that there’s someone currently accumulating under the ‘cover’ of Lombard doing the reverse.
If the results are great, I firmly believe that MED will be the new Viagra. Furthermore, I don’t think there is a requirement for it to be priced closely to that of Viagra. Most ED sufferers are going to be in their 30’s onwards, and as such, won’t (in general) be having ‘special nights/days’ on a huge number of occasions per week or month. If the results are great, it will be clear that MED is a far better alternative than Viagra and hence, even with a price differential, why would users want ‘cotton’ when they can have ‘silk’ for their ‘special evening’?
I don’t think that Tony’s opinion that Stada may be the suitor would be right as I don’t think they’d be able to compete with the Tier 1 players.
Am wondering if we do have someone accumulating at the moment, if it may be a potential suitor? I’m not 100% clued up on the RNS laws for this but I believe there wouldn’t need to be an RNS until 10% was breached? If this was the case, if I were a suitor I’d remain just under the radar (10%) and if the results are great, buy like mad till you reach the level where you’re allowed to reach (30%?)! The stock price would ‘pop’ but even if you’re paying eg £1.50 per share, it’s still an absolute bargain compared to what you’ll have to pay in a takeover negotiation where there are multiple interested parties (& there’d be high volume available as holders ‘cash in’ directly after the news announcement).
Perhaps wishful thinking but perhaps not? :))
Either way, I totally agree with Daring Aberdeen that ‘all hell will break loose’ if the results are great.